Avocado pricing hurts Calavo’s first quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Analyst remains confident in Inogen despite huge selloff
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
American Riveria expands presence with new Santa Maria bank
Following a successful launch at the beginning of February, American Riviera Bank’s new outpost in Santa Maria is set to meet the diverse financial needs of a region rapidly expanding both economically and as a community. And in just that short time, things are going well, if not better than expected, executives at the bank Read More →
Portfolio Watch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment revenue exceeds expectations in the third quarter
AeroVironment, headquartered in Virginia but still maintains operations in Simi Valley and Moorpark, saw a huge bump in revenue when the company released its earnings results for the third quarter after the markets closed March 6. A maker of drones, AeroVironment reported revenue worth $134.4 million for the quarter ended Dec. 31, an increase of Read More →
How small and middle-market companies are preparing for a recession
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind delivers record revenue
MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, delivered a record year for revenue behind its multiple products out in the market. Based in Westlake Village, MannKind generated revenue worth $99.7 million in 2022, up from $75.2 million in 2021. In the fourth quarter, revenue also shot up to $36 Read More →
